Research Project

Project Title:	Phase 3, randomized, double-blind, active versus control cycle to evaluate the safety and efficacy of CCX168 (Avacopan) in patients with cytoplasmic antineutrophil associated vasculitis (ANCA) in combination with rituximab ofosfamide / azathioprine.
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	Phase 3, randomized, double-blind, active versus control cycle to evaluate the safety and efficacy of CCX168 (Avacopan) in patients with cytoplasmic antineutrophil associated vasculitis (ANCA) in combination with rituximab ofosfamide / azathioprine.
Lead principal investigator(s):	Dario Roccatello, Turin
Project Period:	09/2022 - 12/2060
Sponsors:	Industry
ClinicalTrials.gov:	NCT02994927